DK280789D0 - Komplekser af beta-cyclodextrin med salte af ibuprofen, fremgangsmaade til fremstilling af saadanne komplekser og farmaceutiske midler indeholdende disse - Google Patents

Komplekser af beta-cyclodextrin med salte af ibuprofen, fremgangsmaade til fremstilling af saadanne komplekser og farmaceutiske midler indeholdende disse

Info

Publication number
DK280789D0
DK280789D0 DK280789A DK280789A DK280789D0 DK 280789 D0 DK280789 D0 DK 280789D0 DK 280789 A DK280789 A DK 280789A DK 280789 A DK280789 A DK 280789A DK 280789 D0 DK280789 D0 DK 280789D0
Authority
DK
Denmark
Prior art keywords
complexes
ibuprofen
cyclodextrin
beta
salts
Prior art date
Application number
DK280789A
Other languages
English (en)
Other versions
DK280789A (da
Inventor
Christopher Hunter
David Yau
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of DK280789D0 publication Critical patent/DK280789D0/da
Publication of DK280789A publication Critical patent/DK280789A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK280789A 1988-06-09 1989-06-08 Komplekser af beta-cyclodextrin med salte af ibuprofen, fremgangsmaade til fremstilling af saadanne komplekser og farmaceutiske midler indeholdende disse DK280789A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888813682A GB8813682D0 (en) 1988-06-09 1988-06-09 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DK280789D0 true DK280789D0 (da) 1989-06-08
DK280789A DK280789A (da) 1989-12-12

Family

ID=10638367

Family Applications (1)

Application Number Title Priority Date Filing Date
DK280789A DK280789A (da) 1988-06-09 1989-06-08 Komplekser af beta-cyclodextrin med salte af ibuprofen, fremgangsmaade til fremstilling af saadanne komplekser og farmaceutiske midler indeholdende disse

Country Status (18)

Country Link
US (1) US5019563A (da)
EP (1) EP0346006B1 (da)
JP (1) JPH02243649A (da)
KR (1) KR910000138A (da)
AT (1) ATE83924T1 (da)
AU (1) AU609988B2 (da)
CA (1) CA1320192C (da)
DE (1) DE68904121T2 (da)
DK (1) DK280789A (da)
ES (1) ES2052914T3 (da)
FI (1) FI93692C (da)
GB (2) GB8813682D0 (da)
GR (1) GR3006729T3 (da)
IE (1) IE61616B1 (da)
NO (1) NO175039B (da)
NZ (1) NZ229204A (da)
PT (1) PT90760B (da)
ZA (1) ZA893913B (da)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3827974A1 (de) * 1988-08-18 1990-02-22 Boehringer Mannheim Gmbh Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.
DE3922441A1 (de) * 1989-07-07 1991-01-17 Pharmatrans Sanaq Ag Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
FR2660195B1 (fr) * 1990-03-28 1994-10-07 Crinex Sa Laboratoires Composition pharmaceutique a macher, antiinflammatoire et/ou analgesique.
DE69214333T2 (de) * 1991-03-22 1997-04-24 Merck & Co Inc Arzneizubereitung mit hohem Gehalt an Ibuprofenlysinat
DE69231457T2 (de) * 1991-06-21 2001-05-23 Takeda Chemical Industries Ltd Zyklodextrin-Zusammensetzung enthaltend Fumagillol-Derivate
US5321014A (en) * 1991-06-28 1994-06-14 The United States Of America As Represented By The Department Of Health And Human Services Molecular encapsulation and delivery of alkenes alkynes and long chain alkanes, to living mammalian cells
IT1255007B (it) * 1991-07-01 1995-10-11 Altergon Sa Sale solubile dell'ibuprofen c0n n-(2-idrossietil) pirrolidina e composizioni farmaceutiche che li contengono.
GB9207990D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Pharmaceutical composition
IT1272149B (it) * 1993-03-26 1997-06-11 Zambon Spa Composizione farmeceutiche ad attivita' analgesica
HU210922B (en) * 1993-05-24 1995-09-28 Europharmaceuticals Sa Nimesulide alkali salt cyclodextrin inclusion complexes their preparation and pharmaceutical compositions containing them
CN1088600C (zh) * 1993-07-31 2002-08-07 史密丝克莱恩比彻姆有限公司 布洛芬－β－环糊精配合物的用途
US5582351A (en) * 1993-08-09 1996-12-10 Tsau; Josef Convenient to use aspartame and method of making
GB9316580D0 (en) * 1993-08-10 1993-09-29 Smithkline Beecham Plc Pharmaceutical composition
US5866162A (en) * 1993-08-10 1999-02-02 Smithkline Beecham P.L.C. Pharmaceutical composition containing a drug/β-cyclodextrin complex in combination with an acid-base couple
NZ270077A (en) * 1993-12-14 1996-04-26 Lilly Co Eli Aqueous complexes of benzothiophenes and cyclodextrins
US5646131A (en) * 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
CA2190598A1 (en) * 1994-05-27 1995-12-07 Lawrence John Penkler Pharmaceutical composition
BE1008307A3 (fr) * 1994-06-16 1996-04-02 Europharmaceuticals Sa Sel de nimesulide hydrosoluble, solution aqueuse le contenant, sa preparation et son utilisation.
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
US5942501A (en) * 1996-08-16 1999-08-24 Collaborative Laboratories, Inc. Cyclodextrin derivative complex
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US6287603B1 (en) * 1999-09-16 2001-09-11 Nestec S.A. Cyclodextrin flavor delivery systems
ES2171110B1 (es) * 2000-03-03 2003-06-16 Aplicaciones Farmacodinamicas Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion.
US7141555B2 (en) * 2000-12-19 2006-11-28 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US7704975B2 (en) * 2000-12-19 2010-04-27 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
KR100451485B1 (ko) * 2002-03-28 2004-10-06 주식회사종근당 푸마질롤 유도체 또는 그 염의 포접 화합물, 및 이를포함하는 약제학적 조성물
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
US20060233873A1 (en) * 2003-01-24 2006-10-19 Julien Meissonnier Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
GB2429916A (en) * 2004-06-07 2007-03-14 Strides Arcolab Ltd Pharmaceutical composition containing a stable and clear solution of anti-inflammatory drug in soft gelatin capsule and process for producing the same
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
KR100730393B1 (ko) * 2005-06-10 2007-06-20 한국콜마 주식회사 이부프로펜 및 아르기닌을 함유하는 약학 조성물의제조방법
US20070098789A1 (en) * 2005-11-02 2007-05-03 Toru Hibi Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
AU2007227614B2 (en) * 2006-03-16 2011-01-06 Gsk Consumer Healthcare Sarl Solid dosage form containing a taste masked active agent
FR2914187B1 (fr) * 2007-03-28 2011-01-21 Pf Medicament Complexes d'ibuprofene, de cyclodextrines et d'agents ternaires, et leurs utilisations en pharmaceutique.
US20110144207A1 (en) * 2008-08-14 2011-06-16 Shasun Chemicals And Drugs Limited Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
EP2238973A1 (en) 2009-04-07 2010-10-13 Cephalon France Lyophilized preparations of proteasome inhibitors
ES2347754B8 (es) * 2009-04-27 2012-06-04 Laboratorio De Aplicaciones Farmacodinamicas, S.A Suspension oral de lisinato de ibuprofeno
DK2253329T3 (da) * 2009-04-27 2017-01-16 Laboratorio De Aplicaciones Farm S A Oral ibuprofenlysinat-suspension.
US20120101159A1 (en) * 2009-04-27 2012-04-26 Laboratorio De Aplicaciones Farmacodinamicas, S.A. Ibuprofen lysinate oral suspension
TWI504393B (zh) * 2009-06-22 2015-10-21 Wyeth Llc 製備包含異丁苯丙酸鈉之醫藥組合物之方法
CN101978955A (zh) * 2010-11-05 2011-02-23 航天中心医院 右旋布洛芬氨基酸盐片剂及其制备方法
US10098964B2 (en) 2015-03-12 2018-10-16 The Board Of Trustees Of The University Of Illinois Inclusion complexes and methods for making the same
CN114588107B (zh) * 2022-04-06 2023-04-18 河北一品生物医药有限公司 一种布洛芬赖氨酸盐注射液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5646837A (en) * 1979-09-27 1981-04-28 Kowa Yakuhin Kogyo Kk Preparation of ibuprofen clathrate compound
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
US4795698A (en) * 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
CA1298290C (en) * 1987-01-09 1992-03-31 Herand M. Markarian Solution ibuprofen complexes, compositions and processes for preparing the same

Also Published As

Publication number Publication date
GB8911938D0 (en) 1989-07-12
ZA893913B (en) 1990-02-28
FI892780A (fi) 1989-12-10
IE891757L (en) 1989-12-09
JPH02243649A (ja) 1990-09-27
NO175039C (da) 1994-08-24
GB2219585A (en) 1989-12-13
AU609988B2 (en) 1991-05-09
DK280789A (da) 1989-12-12
GR3006729T3 (da) 1993-06-30
AU3492789A (en) 1989-12-14
CA1320192C (en) 1993-07-13
US5019563A (en) 1991-05-28
PT90760B (pt) 1994-10-31
NO175039B (no) 1994-05-16
FI892780A0 (fi) 1989-06-07
NZ229204A (en) 1992-03-26
NO892340D0 (no) 1989-06-07
GB2219585B (en) 1991-11-06
NO892340L (no) 1989-12-11
FI93692B (fi) 1995-02-15
GB8813682D0 (en) 1988-07-13
FI93692C (fi) 1995-05-26
ATE83924T1 (de) 1993-01-15
ES2052914T3 (es) 1994-07-16
PT90760A (pt) 1989-12-29
EP0346006A1 (en) 1989-12-13
DE68904121T2 (de) 1993-05-06
EP0346006B1 (en) 1992-12-30
DE68904121D1 (de) 1993-02-11
KR910000138A (ko) 1991-01-29
IE61616B1 (en) 1994-11-16

Similar Documents

Publication Publication Date Title
DK280789A (da) Komplekser af beta-cyclodextrin med salte af ibuprofen, fremgangsmaade til fremstilling af saadanne komplekser og farmaceutiske midler indeholdende disse
PL261349A1 (en) Method of obtaining an incorporative complex of 7-isopropoxyisoflavone with cyclodextrin
ZA894128B (en) Use of gamma-hydroxybutryic acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism,and the compositions obtained
DK343388A (da) 2,2-dimethylchroman-3-ol-derivater og fremgangsmaade til fremstilling deraf, farmaceutiske midler indeholdende derivaterne samt disse anvendelse til fremstilling af farmaceutiske midler
DK167187D0 (da) Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
IT8219908A0 (it) Derivati di ferro biodisponibile esenti da gastrolesivita',procedimento di preparazione e relative composizioni farmaceutiche.
DK261890D0 (da) Isoindolderivater og salte heraf, fremgangsmaade til fremstilling af disse og antitumorpraeparater indeholdende saadanne forbindelser
NO880179D0 (no) Polymerkomplekser, fremgangsmaate for fremstilling av disse, og farmasoeytiske midler inneholdende disse.
DK0478838T3 (da) Ibuprofen- og S-(+)-ibuprofenpræparater og fremgangsmåder til fremstilling heraf
IT8720271A0 (it) Nuovi derivati dell'ergolene, composizioni farmaceutiche che licontengono e procedimento per lapreparazione dei medesimi.
IT8621934A0 (it) Procedimento per la preparazione di derivati salini dell'acido mercaptoetansolfonico.
IT8867820A0 (it) Procedimento di preparazione di derivati dell'1,4-benzodiazepina-4-one
IT1230503B (it) Acido 8 amino 1 idrossiottan 1,1difosfonico, suoi sali o derivati e relative composizioni farmaceutiche
DK0463139T3 (da) 2,13-disubstituerede ergoliner, deres fremstilling og deres anvendelse i lægemidler
HU00224A9 (en) Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same
IL97715A0 (en) Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer,process for the preparation thereof,and pharmaceutical compositions containing the same
NO172492C (no) Fremgangsmaate for fremstilling av alkalimetall- eller jordalkalimetallsalter av n5-formyl-5,6,7,8-tetrahydrofolsyre
RU92016532A (ru) Бензохиназолиновые соединения, способ их получения, фармацевтическая композиция и способ лечения
IT8622819A0 (it) Procedimento per la preparazione di composti stabilizzanti e composti stabilizzanti cosi' ottenuti.
IT8622386A0 (it) Procedimento per la preparazione di metasilicato di sodio granulare.
IT8919274A0 (it) Acido 7 amino 1 idrossieptan 1 difosfonico suoi sali o derivati e relative composizioni farmaceutiche.
IT8822479A0 (it) Sale di calcio biodisponibile e relative composizoni farmaceutiche.
IT8619873A0 (it) Procedimento per la preparazione di derivati dell'azetidinone.
IT8620211A0 (it) Sale di acido 5'-adenilico, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT8721255A0 (it) 2 tiolpropionil arginine, loro sali, procedimento per la loro preparazione e relative composizioni farmaceutiche.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment